On the morning of the 23rd, around 10 stocks sequentially hit the upper price limit on the Korean stock market. Strong buying pressure poured in from the opening of the session, drawing investors' attention to specific stocks.

■ Mirae Nanotech, Bohae Brewing See Overwhelming Buying Pressure

The stock that drew the most attention was Mirae Nanotech. It entered the upper limit at 9,030 won, up 29.93% from the previous trading day, with buy orders at the upper limit exceeding 29.64 million shares, indicating explosive demand. Bohae Brewing also hit the upper limit at 3,040 won, up 29.91%, with trading volume surpassing 17.42 million shares as steady buying continued to flow in. Mohenz also rose to its daily price limit at 4,290 won.

■ Pharmaceutical and Biotech Stocks Join the Rally

Pharmaceutical stocks also showed notable gains. Gyeongnam Pharmaceutical rose 29.75% to 2,320 won, and Cho-A Pharmaceutical climbed 29.89% to 856 won, both reaching the upper limit. BL Farmtech also surged 29.90% to 2,120 won, while Cha AI Healthcare rose 29.98% to 7,500 won, attracting investor interest.

■ Weejit, Vivian, and Others Add to Upper-Limit Streak

In addition, Weejit (1,742 won, 30.00%), Genitics (2,170 won, 29.78%), Seosan (8,120 won, 29.92%), and Vivian (10,980 won, 29.94%) sequentially joined the upper-limit ranks.

■ Combination of Individual Catalysts and Supply-Demand Factors... Caution Urged on Volatility

The market analyzes that a complex interplay of individual stock catalysts and supply-demand factors led to the emergence of numerous upper-limit stocks. In particular, stocks that saw concentrated buy orders from the opening bell accumulated significant waiting buy volumes even after reaching the upper limit, reflecting strong investor sentiment.

However, upper-limit stocks carry high volatility due to short-term price surges, requiring extra caution from investors. Whether trading volume and supply-demand trends continue going forward is expected to serve as a key variable for future stock price movements.

[※ This article was written with the assistance of AI based on publicly available data and market information. The content included is for reference only in making investment decisions and does not constitute a recommendation to buy or sell any specific stock or guarantee any returns. The stock market can fluctuate due to various factors, so investment decisions should be made at the investor's own discretion and responsibility. As some information may be subject to interpretation or errors during the AI analysis process, please be sure to verify official disclosures and corporate announcements before making final investment decisions.]